Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03157713 · ClinicalTrials.gov registry record · NA
Financial Incentives for Weight Reduction Study
A NA study of Obese, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 668
- Enrollment target
- 2
- Study locations
NCT03157713: Completed NA study of Obese, sponsored by University of California, Los Angeles.
NCT03157713 is a NA study of Obese that has completed, run by University of California, Los Angeles. The registered enrollment target is 668 participants, above the 187-participant average among 27 other Obese trials with a reported enrollment target (257% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03157713, a NA study of Obese, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 668 participants
- Enrollment target
- 2
- Study locations
Study Summary
Financial incentives for motivating changes in health behavior, particularly for weight loss in obese individuals, are increasingly being tested by health insurers, employers, and government agencies. However, a key unanswered question regarding weight loss is how to structure these incentive programs to maximize their effectiveness, acceptability to patients, and economic sustainability. Focusing on obese patients living in neighborhoods with a high concentration of low socioeconomic status households, the investigators will compare the impact of financial incentives for weight loss on sustained weight loss, use of evidenced-based therapy, and quality of life, and they will determine their short-term and long-term return on investment.
Primary Outcome
We will obtain weight measurements by weighing before eating without shoes or heavy garments using a digital scale that will be calibrated monthly.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Goal-Directed Financial Incentives
- BEHAVIORAL Outcome-based Financial Incentives
Study Locations (2)
California
- Olive View-UCLA Medical Center - Sylmar
New York
- NYU Lutheran Medical Center - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 668 participants |
| Start Date | 2017-10-16 |
| Est. Completion | 2021-03-22 |
| Phase | NA |
What the finished NCT03157713 record still lists
NCT03157713 is an interventional study that assigns participants to a tested intervention. The registered 668 participants enrollment target is mid-sized for trials with a published cap, above the 187-participant average among 27 other Obese trials with a reported enrollment target (257% higher).
The record links to 1 condition, with Obese appearing as the primary indexed condition, and to 3 interventions - of which Enhanced Usual Care is the first listed.
NCT03157713 reports a single indexed study location in California, New York.
Frequently Asked Questions
What is clinical trial NCT03157713 about?
NCT03157713 is a clinical study titled "Financial Incentives for Weight Reduction Study". Financial incentives for motivating changes in health behavior, particularly for weight loss in obese individuals, are increasingly being tested by health insurers, employers, and government agencies. However, a key unanswered question regarding weight loss is how to structure these incentive progra...
What is the current status of trial NCT03157713?
This trial is currently completed. It is a NA study. The enrollment target is 668 participants. The study started on 2017-10-16. Estimated completion is 2021-03-22.
What conditions does trial NCT03157713 study?
This clinical trial studies the following conditions: Obese.
What interventions are being tested in trial NCT03157713?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Goal-Directed Financial Incentives (BEHAVIORAL), Outcome-based Financial Incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT03157713?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03157713 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obese
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03157713's enrollment target sits among peer trials
668 2nd of 27 the highest of 27 other Obese trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obese trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men
ACTIVE NOT RECRUITING · NA
-
Brain Fuel - Morning Nutrition and Cognitive Function
ACTIVE NOT RECRUITING · NA
-
The Expecting Study
ACTIVE NOT RECRUITING · NA
-
Olive Oil Polyphenols and Cardiovascular Health Biomarkers
ACTIVE NOT RECRUITING · NA
-
mFit: The Mobile Fitness Project
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04155034 · 668 participants · Phase 3
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
- NCT04179981 · 668 participants · NA
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- NCT05006482 · 668 participants · Phase 3
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI